-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $175

Benzinga·10/30/2026 22:48:36
Listen to the news
JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $165 to $175.